摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aS,4R,5R,6S,7R,7aR)-5,6,7-Tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-4-ol | 131233-63-1

中文名称
——
中文别名
——
英文名称
(3aS,4R,5R,6S,7R,7aR)-5,6,7-Tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-4-ol
英文别名
(3aS,4R,5R,6S,7R,7aR)-2,2-dimethyl-5,6,7-tris(phenylmethoxy)-3a,4,5,6,7,7a-hexahydro-1,3-benzodioxol-4-ol
(3aS,4R,5R,6S,7R,7aR)-5,6,7-Tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-4-ol化学式
CAS
131233-63-1
化学式
C30H34O6
mdl
——
分子量
490.596
InChiKey
WORUQUKKISUTQP-LQZPZKLRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    36
  • 可旋转键数:
    9
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    66.4
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    (3aS,4R,5R,6S,7R,7aR)-5,6,7-Tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-4-ol 在 palladium on activated charcoal 盐酸 、 sodium tetrahydroborate 、 氢气三氧化硫吡啶三乙胺 作用下, 以 甲醇乙醇溶剂黄146二甲基亚砜 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 26.42h, 生成 epi-Inositol
    参考文献:
    名称:
    衍生自(±)-3,4,5-三-O-苄基-1,2-O-异亚丙基-肌醇的酮的反应:表肌醇和4-C-甲基-外消旋衍生物的制备表-[(±)-异米醇]和4-C-甲基-肌醇[(±)-米醇]
    摘要:
    摘要用吡啶-SO3络合物在甲基亚砜中氧化(±)-3,4,5-三-O-苄基-1,2-O-异亚丙基-肌醇-丁酮几乎仅是相应的表肌醇衍生物。酮与重氮甲烷反应生成环氧化物,用氢化铝锂还原该环氧化物得到4-C-甲基-肌醇衍生物,酮与甲基碘化镁的反应得到异构体4-C-甲基-表肌醇衍生物。
    DOI:
    10.1016/s0008-6215(96)00330-8
  • 作为产物:
    描述:
    (±)-1,2:5,6-di-O-isopropylidene-myo-inositol 在 3 A molecular sieve 、 四丁基溴化铵 、 sodium hydride 、 二正丁基氧化锡对甲苯磺酸2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 二氯甲烷N,N-二甲基甲酰胺丙酮乙腈 为溶剂, 反应 1.58h, 生成 (3aS,4R,5R,6S,7R,7aR)-5,6,7-Tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-4-ol
    参考文献:
    名称:
    The synthesis and resolution of (±)-1,5,6-tri-O-benzyl-myo-inositol
    摘要:
    Racemic 1,5,6-tri-O-benzyl-myo-inositol was prepared by five routes and converted into 1,5,6-tri-O-benzyl-2,3-O-isopropylidene-myo-inositol, the camphanates of which were readily separated by chromatography. The absolute configurations of the chiral derivatives were established by their conversion into the known chiral 1,4,5,6-tetra-O-benzyl-myo-inositols. 1D-1,5,6-Tri-O-benzyl-2,3-O-isopropylidene-myo-inositol was converted into 1D-1,3,5,6-tetra-O-benzyl-myo-inositol and thence into 1D-2,4-di-O-methyl-myo-inositol. 1D-1,5,6-Tri-O-benzyl-myo-inositol was converted into 1D-1,2,5,6-tetra-O-benzyl-myo-inositol, the diacetate of which is a chiral analogue of "thermosalient crystals". The potential of the above compounds for the synthesis of natural products is surveyed.
    DOI:
    10.1016/0008-6215(90)80132-m
点击查看最新优质反应信息

文献信息

  • Nickel-Catalyzed Stereoselective Glycosylation with C(2)-<i>N</i>-Substituted Benzylidene <scp>d</scp>-Glucosamine and Galactosamine Trichloroacetimidates for the Formation of 1,2-<i>cis</i>-2-Amino Glycosides. Applications to the Synthesis of Heparin Disaccharides, GPI Anchor Pseudodisaccharides, and α-GalNAc
    作者:Enoch A. Mensah、Fei Yu、Hien M. Nguyen
    DOI:10.1021/ja106682m
    日期:2010.10.13
    α-selectivity. The reactive sites of the nucleophiles or the nature of the protecting groups have little effect on the α-selectivity. This methodology has also been successfully applied to both disaccharide donors and acceptors to provide the corresponding oligosaccharides in high yields and α-selectivity. The efficacy of the nickel procedure has been further applied toward the preparation of heparin disaccharides
    1,2-cis-2-amino glycosides 是在各种生物学上重要的寡糖和糖肽中发现的关键成分。尽管 1,2-cis-2-基糖苷的合成取得了显着进展,但目前最先进方法的缺点包括底物范围有限、产率低、反应时间长和异头混合物。我们开发了一种通过催化的 α-选择性糖基化与 C(2)-N-取代的亚苄基 D-葡糖胺和半乳糖胺三酰亚胺合成 1,2-顺-2-基糖苷的新方法。这些糖基供体能够与多种醇偶联,以高产率提供具有出色 α 选择性的糖缀合物。此外,仅需要亚化学计量的 (5-10 mol%) 才能在 25 °C 下进行反应。目前的方法依赖于配体配合物的性质来控制 α 选择性。亲核试剂的反应位点或保护基团的性质对α-选择性几乎没有影响。该方法也已成功应用于二糖供体和受体,以高产率和 α 选择性提供相应的寡糖过程的功效已进一步应用于制备肝素二糖、GPI 锚定假二糖和 α-Glu
  • Synthesis of optically active myo-inositol derivatives starting from phytic acid
    作者:Corinne Blum、Nicola Rehnberg、Bernard Spiess、Gilbert Schlewer
    DOI:10.1016/s0008-6215(97)00131-6
    日期:1997.8
    Abstract Phytic acid treated with Baker's yeast gave d -myo-inositol-1,2,6-tris(phosphate) (α-trinositol) which was transformed into (+)- d -1,2-O- isopropylidene -myo- inositol and (−)- d -3,4,5- tri -O- benzyl -myo- inositol , two key intermediates in the synthesis of optically active myo-inositol derivatives and related compounds.
    摘要用贝克酵母处理过的植酸得到d-肌醇-1,2-,6-三(磷酸)(α-三糖醇),然后转化为(+)-d-1,2-O-异亚丙基-肌醇和(-)-d -3,4,5-三-O-苄基-肌醇,这是光学活性肌醇衍生物和相关化合物合成中的两个关键中间体。
  • Strategies for stereocontrol at C1 or C2 in syntheses of α‐glucosaminides
    作者:Bert Fraser‐Reid、G. Anilkumar、Latha G. Nair、Lars Olsson、Mercedes Garcia Martin、Jacquitta K. Daniels
    DOI:10.1560/kdp7-d0ba-bn04-3h3a
    日期:2000.12
    Abstract

    The C1 and C2 stereocenters of α‐glucosaminides can be prepared by establishing the stereocenters in either order. For the former, a C2‐azido glucosyl donor is prepared first, and the restraining effect of a 4,6‐O‐benzylidene ring is used to induce α‐coupling. For the latter, the C1 linkage is prepared first by use of an n‐pentenyl‐manno‐1,2‐orthoester donor which ensures (a) clean α‐coupling and (b) a convenient C2‐ester. The C2‐ester is replaced with a triflate leaving group, and nucleophilic displacement is effected by use of a hypervalent silicon azide.

    摘要 α-氨基葡萄糖苷的 C1 和 C2 立体中心可以按两种顺序制备。对于前者,首先制备 C2-叠氮葡萄糖基供体,然后利用 4,6-O-亚苄基环的限制作用诱导 α-偶联。对于后者,首先使用正戊烯基-甘露-1,2-正酯供体制备 C1 连接,以确保 (a) α 偶联干净利落,(b) C2- 酯方便使用。C2- 酯被三酸酯离去基团取代,并通过使用超价叠氮实现亲核置换。
  • Efficient syntheses of chiral myo-inositol derivatives—key intermediates in glycosylphosphatidylinositol (GPI) syntheses
    作者:Fei Yu、Zhongwu Guo
    DOI:10.1016/j.bmcl.2009.03.151
    日期:2009.7
    A facile and effective method was developed for large-scale syntheses of myo-inositol derivatives with the 1,2,6-O-positions differentiated from each other and from other positions as well. The syntheses started from methyl alpha-D-glucopyranoside, and the key steps are Ferrier rearrangement and a series of other regioselective and stereoselective reactions. The target compounds are key intermediates in the synthesis of GPIs. (C) 2009 Elsevier Ltd. All rights reserved.
  • The alkylation of dibutylstannylene derivatives of 1,2-O-isopropylidene-myo-inositol.
    作者:Jill Gigg、Roy Gigg、Eloisa Martin-Zamora
    DOI:10.1016/s0040-4039(00)73573-8
    日期:1993.4
    Benzylation (or allylation) of 1,2-O-isopropylidene-myo-inositol in the presence of an excess of dibutyltin oxide gives, as major products, the readily isolable 3,4,6- (12) and 3,5,6-tri-O-alkyl (13) derivatives which are valuable intermediates for the synthesis of inositol phosphates of the phosphatidylinositol cycle.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫